RenalGuard system in high-risk patients for contrast-induced acute kidney injury
Authors:
Open Access
- 1 March 2016
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 173, 67-76
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana Ricerca sul Cancro (10620)
- MERIT (RBNE08E8CZ_002)
This publication has 25 references indexed in Scilit:
- Feasibility study of the RenalGuard™ balanced hydration system: A novel strategy for the prevention of contrast-induced nephropathy in high risk patientsInternational Journal of Cardiology, 2013
- A Novel Tool for Reliable and Accurate Prediction of Renal Complications in Patients Undergoing Percutaneous Coronary InterventionJACC, 2013
- Prevention of Contrast Nephropathy by Furosemide With Matched HydrationJACC: Cardiovascular Interventions, 2012
- Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II)Circulation, 2011
- Cystatin C and Contrast-Induced Acute Kidney InjuryCirculation, 2010
- Contrast-Induced Nephropathy and Long-Term Adverse EventsClinical Journal of the American Society of Nephrology, 2009
- Contrast-Induced Acute Kidney InjuryJACC, 2008
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathyJACC, 1999
- Dosing of contrast material to prevent contrast nephropathy in patients with renal diseaseThe American Journal of Medicine, 1989